Glutamate, excitotoxicity and amyotrophic lateral sclerosis

Area of Science:

• Neuroscience
• Molecular Biology
• Neurodegenerative Diseases

Background:

• Amyotrophic lateral sclerosis (ALS) research focuses on motor neuron injury mechanisms, including the glutamate hypothesis.
• Glutamate receptors exhibit diverse structures due to gene products, splice variants, and RNA editing.
• Abnormal glutamate receptor activation is a key pathway implicated in neuronal death.

Purpose of the Study:

• To investigate the molecular profile of glutamate receptors in human motor neurons.
• To identify specific molecular features contributing to motor neuron vulnerability in ALS.
• To review evidence linking glutamatergic neurotransmission disturbances to ALS pathology.

Main Methods:

• Analysis of glutamate receptor expression in human motor neurons.
• Identification of molecular features like calcium-binding proteins and AMPA receptor subunits.
• Review of existing evidence on glutamatergic neurotransmission in ALS patients.

Main Results:

• Human motor neurons express a distinct profile of AMPA receptors.
• Low expression of calcium-binding proteins and the GluR2 AMPA receptor subunit identified in vulnerable motor neuron groups.
• Eight lines of evidence support disturbances in glutamatergic neurotransmission in ALS.

Conclusions:

• Vulnerable motor neurons may be susceptible to calcium-mediated toxicity due to low GluR2 subunit expression.
• Disturbances in glutamatergic neurotransmission are linked to ALS pathogenesis.
• Therapeutic strategies targeting glutamate receptors and downstream pathways show promise for ALS treatment.